<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33632171</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.</ArticleTitle><Pagination><StartPage>221</StartPage><MedlinePgn>221</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">221</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-021-05927-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Loss of smell and/or taste are cardinal symptoms of COVID-19. 'Long-COVID', persistence of symptoms, affects around one fifth of people. However, data regarding the clinical resolution of loss of smell and/or taste are lacking. In this study we assess smell and taste loss resolution at 4-6&#x2009;week follow-up, aim to identify risk factors for persistent smell loss and describe smell loss as a feature of long-COVID in a community cohort in London with known SARS-CoV-2 IgG/IgM antibody status. We also compare subjective and objective smell assessments in a subset of participants.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Four hundred sixty-seven participants with acute loss of smell and/or taste who had undergone SARS-CoV-2 IgG/IgM antibody testing 4-6&#x2009;weeks earlier completed a follow-up questionnaire about resolution of their symptoms. A subsample of 50 participants completed an objective olfactory test and results were compared to subjective smell evaluations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">People with SARS-CoV-2 antibodies with an acute loss of sense of smell and taste were significantly less likely to recover their sense of smell/taste than people who were seronegative (smell recovery: 57.7% vs. 72.1%, p&#x2009;=&#x2009;0.027. taste recovery 66.2% vs. 80.3%, p&#x2009;=&#x2009;0.017). In SARS-CoV-2 positive participants, a higher percentage of male participants reported full resolution of smell loss (72.8% vs. 51.4%; p&#x2009;&lt;&#x2009;0.001) compared to female participants, who were almost 2.5-times more likely to have ongoing smell loss after 4-6&#x2009;weeks (OR 2.46, 95%CI 1.47-4.13, p&#x2009;=&#x2009;0.001). Female participants with SARS-CoV-2 antibodies and unresolved smell loss and unresolved taste loss were significantly older (&gt;&#x2009;40&#x2009;years) than those who reported full resolution. Participants who experienced parosmia reported lower smell recovery rates and participants with distorted taste perception lower taste recovery rates. Parosmia had a significant association to unresolved smell loss (OR 2.47, 95%CI 1.54-4.00, p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although smell and/or taste loss are often transient manifestations of COVID-19, 42% of participants had ongoing loss of smell, 34% loss of taste and 36% loss of smell and taste at 4-6&#x2009;weeks follow-up, which constitute symptoms of 'long-COVID'. Females (particularly &gt;&#x2009;40&#x2009;years) and people with a distorted perception of their sense of smell/taste are likely to benefit from prioritised early therapeutic interventions.</AbstractText><AbstractText Label="TRIALS REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT04377815 Date of registration: 23/04/2020.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Makaronidis</LastName><ForeName>Janine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UCL Centre for Obesity Research, Division of Medicine, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bariatric Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Firman</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UCL Centre for Obesity Research, Division of Medicine, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magee</LastName><ForeName>Cormac G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>UCL Centre for Obesity Research, Division of Medicine, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bariatric Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mok</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UCL Centre for Obesity Research, Division of Medicine, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bariatric Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balogun</LastName><ForeName>Nyaladzi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UCL Centre for Obesity Research, Division of Medicine, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lechner</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UCL Cancer Institute, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carnemolla</LastName><ForeName>Alisia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UCL Centre for Obesity Research, Division of Medicine, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batterham</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0002-5477-8585</Identifier><AffiliationInfo><Affiliation>UCL Centre for Obesity Research, Division of Medicine, University College London, London, UK. r.batterham@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bariatric Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK. r.batterham@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Health Research, UCLH Biomedical Research Centre, London, UK. r.batterham@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04377815</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>RP-2015-06-005</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BRC751</GrantID><Agency>National Institute for Health Research</Agency><Country/></Grant><Grant><GrantID>NA</GrantID><Agency>Sir Jules Thorn Charitable Trust</Agency><Country/></Grant><Grant><GrantID>RP-2015-06-005</GrantID><Agency>Health Technology Assessment Programme</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="N">Ageusia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008131" MajorTopicYN="N" Type="Geographic">London</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="N">Olfaction Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 IgG/IgM</Keyword><Keyword MajorTopicYN="N">Smell loss</Keyword><Keyword MajorTopicYN="N">Smell recovery</Keyword><Keyword MajorTopicYN="N">Taste loss</Keyword><Keyword MajorTopicYN="N">Taste recovery</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33632171</ArticleId><ArticleId IdType="pmc">PMC7905973</ArticleId><ArticleId IdType="doi">10.1186/s12879-021-05927-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-021-05927-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Coronavirus disease (COVID-19) pandemic 2020 [cited 2020 22 June]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32277751</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaronidis J, Mok J, Balogun N, Magee CG, Omar RZ, Carnemolla A, et al. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: an observational cohort study. PLoS Med. 2020;17(10):e1003358. doi: 10.1371/journal.pmed.1003358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003358</ArticleId><ArticleId IdType="pmc">PMC7529306</ArticleId><ArticleId IdType="pubmed">33001967</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. 2020;2020:10.19.20214494.</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19 nice.org.uk: NICE Guidance; 2021 [Available from: https://www.nice.org.uk/guidance/NG188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS. Office for National Statistics. The prevalence of long COVID symptoms and COVID-19 complications. 2020 [Available from: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications.</Citation></Reference><Reference><Citation>Soler ZM, Patel ZM, Turner JH, Holbrook EH. A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol. 2020;10(7):814&#x2013;820. doi: 10.1002/alr.22578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22578</ArticleId><ArticleId IdType="pmc">PMC7262311</ArticleId><ArticleId IdType="pubmed">32271490</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope. 2007;117(2):272&#x2013;277. doi: 10.1097/01.mlg.0000249922.37381.1e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlg.0000249922.37381.1e</ArticleId><ArticleId IdType="pmc">PMC7165544</ArticleId><ArticleId IdType="pubmed">17277621</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Borsetto D, Fabbris C, Spinato G, Frezza D, Menegaldo A, et al. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Chary E, Carsuzaa F, Trijolet JP, Capitaine AL, Roncato-Saberan M, Fouet K, et al. Prevalence and recovery from olfactory and gustatory dysfunctions in Covid-19 infection: a prospective multicenter study. Am J Rhinol Allergy. 2020;34(5):686&#x2013;693. doi: 10.1177/1945892420930954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1945892420930954</ArticleId><ArticleId IdType="pmc">PMC7418272</ArticleId><ArticleId IdType="pubmed">32527141</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte MS, Klussmann JP, Luers JC. Persisting olfactory dysfunction in patients after recovering from COVID-19. J Inf Secur. 2020;81(3):e58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313498</ArticleId><ArticleId IdType="pubmed">32592702</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>ClinicalTrials.gov. Coronavirus Smell Therapy for Anosmia Recovery 2021 [Available from: https://www.clinicaltrials.gov/ct2/show/NCT04422275.</Citation></Reference><Reference><Citation>Croy I, Nordin S, Hummel T. Olfactory disorders and quality of life--an updated review. Chem Senses. 2014;39(3):185&#x2013;194. doi: 10.1093/chemse/bjt072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjt072</ArticleId><ArticleId IdType="pubmed">24429163</ArticleId></ArticleIdList></Reference><Reference><Citation>Elabscience. COVID-19 IgG and IgM [Available from: https://www.elabscience.com/p-covid_19_igg_igm_rapid_test-375335.html.</Citation></Reference><Reference><Citation>Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94(2 Pt 1):176&#x2013;178. doi: 10.1288/00005537-198402000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1288/00005537-198402000-00004</ArticleId><ArticleId IdType="pubmed">6694486</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science (New York, NY) 2020;370(6521):1227. doi: 10.1126/science.abd7728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd7728</ArticleId><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodda LB, Netland J, Shehata L, Pruner KB, Morawski PA, Thouvenel CD, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184(1):169&#x2013;183. doi: 10.1016/j.cell.2020.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.029</ArticleId><ArticleId IdType="pmc">PMC7682481</ArticleId><ArticleId IdType="pubmed">33296701</ArticleId></ArticleIdList></Reference><Reference><Citation>Meini S, Suardi LR, Busoni M, Roberts AT, Fortini A. Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Otorhinolaryngol. 2020;277(12):3519&#x2013;3523. doi: 10.1007/s00405-020-06102-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06102-8</ArticleId><ArticleId IdType="pmc">PMC7271634</ArticleId><ArticleId IdType="pubmed">32500326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Era V, Farri F, Garzaro G, Gatto M, Aluffi Valletti P, Garzaro M. Smell and taste disorders during COVID-19 outbreak: cross-sectional study on 355 patients. Head Neck. 2020;42(7):1591&#x2013;1596. doi: 10.1002/hed.26288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26288</ArticleId><ArticleId IdType="pmc">PMC7300750</ArticleId><ArticleId IdType="pubmed">32524707</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Hopkins C, Petrocelli M, Lechien JR, Chiesa-Estomba CM, Salzano G, et al. Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020;134(8):703&#x2013;709. doi: 10.1017/S0022215120001826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022215120001826</ArticleId><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Journe F, Hans S, Chiesa-Estomba CM, Mustin V, Beckers E, et al. Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front Med (Lausanne) 2020;7:582802. doi: 10.3389/fmed.2020.582802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.582802</ArticleId><ArticleId IdType="pmc">PMC7732577</ArticleId><ArticleId IdType="pubmed">33330539</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Corbellini &#xc1;, Chico-Garc&#xed;a JL, Mart&#xed;nez-Poles J, Rodr&#xed;guez-Jorge F, Natera-Villalba E, G&#xf3;mez-Corral J, et al. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study. Eur J Neurol. 2020;27(9):1738&#x2013;1741. doi: 10.1111/ene.14273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14273</ArticleId><ArticleId IdType="pmc">PMC7264557</ArticleId><ArticleId IdType="pubmed">32320508</ArticleId></ArticleIdList></Reference><Reference><Citation>Reden J, Maroldt H, Fritz A, Zahnert T, Hummel T. A study on the prognostic significance of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol. 2007;264(2):139&#x2013;144. doi: 10.1007/s00405-006-0157-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-006-0157-0</ArticleId><ArticleId IdType="pubmed">17006637</ArticleId></ArticleIdList></Reference><Reference><Citation>Leopold DA, Loehrl TA, Schwob JE. Long-term follow-up of surgically treated phantosmia. Arch Otolaryngol Head Neck Surg. 2002;128(6):642&#x2013;647. doi: 10.1001/archotol.128.6.642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.128.6.642</ArticleId><ArticleId IdType="pubmed">12049557</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Sabha M, Damm M, Philpott C, Oleszkiewicz A, H&#xe4;hner A, et al. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training. The Laryngoscope. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33210732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35(18):e174. doi: 10.3346/jkms.2020.35.e174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e174</ArticleId><ArticleId IdType="pmc">PMC7211515</ArticleId><ArticleId IdType="pubmed">32383370</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhong HJ, Chung SK, Doty RL. Estrogen protects against 3-methylindole-induced olfactory loss. Brain Res. 1999;824(2):312&#x2013;315. doi: 10.1016/S0006-8993(99)01241-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(99)01241-X</ArticleId><ArticleId IdType="pubmed">10196466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan BP, Tonsor M, Struble RG. Acute responses to estradiol replacement in the olfactory system of apoE-deficient and wild-type mice. Brain Res. 2010;1343:66&#x2013;74. doi: 10.1016/j.brainres.2010.04.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.04.070</ArticleId><ArticleId IdType="pmc">PMC2932439</ArticleId><ArticleId IdType="pubmed">20447382</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan CH, Prajapati DP, Ritter ML, DeConde AS. Persistent smell loss following undetectable SARS-CoV-2. Otolaryngol Head Neck Surg. 2020;163(5):923&#x2013;925. doi: 10.1177/0194599820934769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820934769</ArticleId><ArticleId IdType="pmc">PMC8809452</ArticleId><ArticleId IdType="pubmed">32513065</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavazzana A, Larsson M, M&#xfc;nch M, H&#xe4;hner A, Hummel T. Postinfectious olfactory loss: a retrospective study on 791 patients. Laryngoscope. 2018;128(1):10&#x2013;15. doi: 10.1002/lary.26606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.26606</ArticleId><ArticleId IdType="pubmed">28556265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurol Taiwanica. 2006;15(1):26&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16599281</ArticleId></ArticleIdList></Reference><Reference><Citation>Erskine SE, Philpott CM. An unmet need: patients with smell and taste disorders. Clin Otolaryngol. 2020;45(2):197&#x2013;203. doi: 10.1111/coa.13484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13484</ArticleId><ArticleId IdType="pubmed">31856420</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Lechien JR, Saussez S. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses. 2020;110406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7678428</ArticleId><ArticleId IdType="pubmed">33246692</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryche B, St Albin A, Murri S, Lac&#xf4;te S, Pulido C, Ar Gouilh M, et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun. 2020;89:579&#x2013;586. doi: 10.1016/j.bbi.2020.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.032</ArticleId><ArticleId IdType="pmc">PMC7332942</ArticleId><ArticleId IdType="pubmed">32629042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Prajapati DP, Shahrvini B, MacDonald BV, Crawford KL, Lechner M, DeConde AS, et al. Association of subjective olfactory dysfunction and 12-item odor identification testing in ambulatory COVID-19 patients. Int Forum Allergy Rhinol. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32964657</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>